JPS62262947A - Health tea containing ginkgo extract - Google Patents
Health tea containing ginkgo extractInfo
- Publication number
- JPS62262947A JPS62262947A JP10527986A JP10527986A JPS62262947A JP S62262947 A JPS62262947 A JP S62262947A JP 10527986 A JP10527986 A JP 10527986A JP 10527986 A JP10527986 A JP 10527986A JP S62262947 A JPS62262947 A JP S62262947A
- Authority
- JP
- Japan
- Prior art keywords
- tea
- ginkgo extract
- extract
- ginkgo biloba
- ginkgo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 244000269722 Thea sinensis Species 0.000 title claims abstract description 37
- 239000000284 extract Substances 0.000 title claims abstract description 19
- 235000008100 Ginkgo biloba Nutrition 0.000 title claims abstract description 17
- 235000011201 Ginkgo Nutrition 0.000 title claims abstract description 14
- 244000194101 Ginkgo biloba Species 0.000 title description 4
- -1 etc. Chemical class 0.000 claims abstract description 21
- 229930182470 glycoside Natural products 0.000 claims abstract description 18
- 241000218628 Ginkgo Species 0.000 claims abstract description 13
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims abstract description 10
- 229930003944 flavone Natural products 0.000 claims abstract description 10
- 235000011949 flavones Nutrition 0.000 claims abstract description 10
- 150000003505 terpenes Chemical class 0.000 claims abstract description 10
- 235000007586 terpenes Nutrition 0.000 claims abstract description 10
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- MOLPUWBMSBJXER-YDGSQGCISA-N bilobalide Chemical compound O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 claims abstract description 8
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims abstract description 8
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 claims abstract description 4
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims abstract description 4
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229930184727 ginkgolide Natural products 0.000 claims abstract description 4
- 235000008777 kaempferol Nutrition 0.000 claims abstract description 4
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempherol Natural products C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 claims abstract description 4
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 claims abstract description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N quercetin Natural products C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000005875 quercetin Nutrition 0.000 claims abstract description 4
- 229960001285 quercetin Drugs 0.000 claims abstract description 4
- YXHVCZZLWZYHSA-FPLPWBNLSA-N Ginkgoic acid Chemical compound CCCCCC\C=C/CCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-FPLPWBNLSA-N 0.000 claims abstract 3
- TUGAUFMQYWZJAB-FPLPWBNLSA-N 5-[(8Z)-pentadec-8-enyl]resorcinol Chemical compound CCCCCC\C=C/CCCCCCCC1=CC(O)=CC(O)=C1 TUGAUFMQYWZJAB-FPLPWBNLSA-N 0.000 claims abstract 2
- SRLTUZDQBFYLQI-FPLPWBNLSA-N Bilobol Natural products Oc1c(CCCCCCC/C=C\CCCCCC)ccc(O)c1 SRLTUZDQBFYLQI-FPLPWBNLSA-N 0.000 claims abstract 2
- 235000020686 ginkgo biloba extract Nutrition 0.000 claims description 26
- 239000009429 Ginkgo biloba extract Substances 0.000 claims description 25
- 229940068052 ginkgo biloba extract Drugs 0.000 claims description 25
- 150000002989 phenols Chemical class 0.000 claims description 2
- 239000002075 main ingredient Substances 0.000 claims 1
- 235000013616 tea Nutrition 0.000 abstract description 27
- 239000000796 flavoring agent Substances 0.000 abstract description 9
- 235000019634 flavors Nutrition 0.000 abstract description 9
- 235000006468 Thea sinensis Nutrition 0.000 abstract description 8
- 208000006011 Stroke Diseases 0.000 abstract description 5
- 239000000843 powder Substances 0.000 abstract description 5
- 235000020279 black tea Nutrition 0.000 abstract description 4
- 235000009569 green tea Nutrition 0.000 abstract description 4
- 235000020333 oolong tea Nutrition 0.000 abstract description 4
- 235000019640 taste Nutrition 0.000 abstract description 4
- 238000002156 mixing Methods 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 3
- YXHVCZZLWZYHSA-UHFFFAOYSA-N (Z)-6-[8-pentadecenyl]salicylic acid Natural products CCCCCCC=CCCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-UHFFFAOYSA-N 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010008190 Cerebrovascular accident Diseases 0.000 abstract 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 230000001976 improved effect Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 235000019658 bitter taste Nutrition 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 229920001864 tannin Polymers 0.000 description 6
- 239000001648 tannin Substances 0.000 description 6
- 235000018553 tannin Nutrition 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 230000007721 medicinal effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- 240000005979 Hordeum vulgare Species 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 208000013600 Diabetic vascular disease Diseases 0.000 description 1
- 240000008955 Dioscorea japonica Species 0.000 description 1
- 235000005251 Dioscorea japonica Nutrition 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000009101 diabetic angiopathy Diseases 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 229940106580 ginkgo biloba leaf extract Drugs 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Landscapes
- Tea And Coffee (AREA)
Abstract
Description
【発明の詳細な説明】 産業上の利用分野 本発明は、イチョウ抽出物の入った健康茶に関する。[Detailed description of the invention] Industrial applications The present invention relates to a health tea containing ginkgo biloba extract.
従来技術並びに問題点 イチョウは古くから去痰、鎮咳、解毒、治淋。Conventional technology and problems Ginkgo biloba has been used as an expectorant, antitussive, detoxifier, and healing agent since ancient times.
瀬尿抑制、滋養の効があるとされ、民間薬として用いら
れており、ガン、肺結核、タコ、ウオノ目等の治療にも
利用されている。一方、イチ1つ葉より抽出したエキス
には血管拡張、血流増大、血管系の老化防止、特に脳及
び皮膚の末梢血流の改善、精神的症候の改善等の効果が
あり、脳動脈硬化、老人ボケ、糖尿病性血管障害。It is said to have the effect of suppressing urination and being nourishing, and is used as a folk medicine, and is also used to treat cancer, pulmonary tuberculosis, calluses, and urticaria. On the other hand, the extract extracted from a single Japanese yam leaf has the effect of dilating blood vessels, increasing blood flow, preventing aging of the vascular system, improving peripheral blood flow in the brain and skin in particular, and improving mental symptoms, as well as cerebral arteriosclerosis. , senility, diabetic vascular disease.
皮膚血行障害、精神障害等の治療を目的とした現代療法
にも用いられている。It is also used in modern therapies to treat skin blood circulation disorders, mental disorders, etc.
しかしながら、上記のように脳卒中や老人ボケの予防並
びに治療に効果があるイチョウ葉抽出エキスは、現在、
ヨーロッパにおいて医薬品として用いられているにすぎ
ず、日本国内での利用はほとんど検討されていない。一
部にこれを健康維持食品の中に含むと称し販売するよう
なことが行なわれているが、その香味、風味は決して良
いものではなく、食品というよりはむしろ薬品に近いも
のであるばかりか、有効成分とされろフラボン配糖体や
テルペン類の有無も明確ではない。However, as mentioned above, ginkgo biloba extract, which is effective in preventing and treating stroke and senility, is currently not available.
It is only used as a medicine in Europe, and its use in Japan has hardly been considered. In some cases, this product is sold under the guise that it is included in health maintenance foods, but the flavor and aroma are not at all good, and it is more like a medicine than a food. However, it is not clear whether there are flavone glycosides or terpenes as active ingredients.
したがって、脳卒中や老人ボケの予防並びに治療のため
優れた効果を有するイチョウ抽出物を含み、香味、風味
が良く、何人も食することが出来、且つ、有効成分とさ
れるフラボン配糖体やテルペン類を含有し、医療効果の
特性を充分に発揮しうろ食品の開発が求められていた。Therefore, it contains ginkgo biloba extract, which has excellent effects on the prevention and treatment of stroke and senility, has a good flavor and flavor, can be eaten by many people, and contains flavone glycosides and terpenes as active ingredients. There was a need for the development of Uro foods that contain the following and fully exhibit the characteristics of medical effects.
発明の目的
本発明は、脳卒中や老人ボケの予防並びに治療のため優
れた効果を有するイチョウ抽出物を含み、香味、に味が
良く、何人も食することが出来、且つ、有効成分とされ
るフラボン配糖体やテルペン類を含有し医療効果の特性
を充分に発揮し得ろ食品の開発を目的とする。Purpose of the Invention The present invention contains a ginkgo biloba extract that has excellent effects for the prevention and treatment of stroke and senility, has a good flavor and taste, can be eaten by many people, and is an active ingredient. The aim is to develop foods that contain flavone glycosides and terpenes and can fully exhibit the characteristics of medical effects.
イチョウ抽出物に強い苦味を有するが、これはイチョウ
葉中の有効成分とされる、ケルセチン配糖体、ケンフェ
ロール配糖体等のフラボン配糖体及び、ギンコライド、
ビロバライド等のテルペン類そのものの苦味に起因する
。本発明者等はイチョウ抽出物入り健康茶を開発するに
轟り、この苦味物質による医療効果の特性な維持すると
ともに、苦味を適度におさえ、そのほのかな苦味を特徴
とする風味を生かすよう、種々検討し、既に目的?:満
足させ得ろ炭酸飲料の開発に成功している。しかしなが
ら飲用者の中には抽出物に由来する苦味に対し、不快感
を持つ人もおり、そういった飲用者の嗜好に合う健康飲
料を提供する必要があった。Ginkgo biloba extract has a strong bitter taste, but this is due to flavone glycosides such as quercetin glycosides and kaempferol glycosides, which are said to be active ingredients in ginkgo biloba leaves, and ginkgolides.
This is due to the bitterness of the terpenes themselves, such as bilobalide. The inventors of the present invention have developed a health tea containing ginkgo biloba extract, and have developed various methods to maintain the characteristic medical effects of this bitter substance, suppress the bitterness to an appropriate level, and make use of the flavor characterized by its faint bitterness. Considering the purpose already? : Successfully developed a carbonated drink that satisfies people. However, some drinkers are uncomfortable with the bitter taste derived from the extract, and there is a need to provide a health drink that suits the tastes of such drinkers.
本発明者等は、イチョウ抽出物の苦味をマスクするよう
な飲料の開発を目的として検討を重ねた結果、イチョウ
抽出物の水溶液中にタンニン類を共存させることにより
苦味がマスクされることを発見した。すなわちタンニン
自身の持つ渋味がイチョウ抽出物に由来する苦味に優先
するためであり、事実、イチョウ抽出物0.1%〜0.
4%を含有する水溶液と、それに0.1%のタンニンを
加えた水溶液とを10人のパネラ−による官能試験で比
較したところ、10人とも前者の場合には苦味、後者の
場合には渋味を感じろことがわがりだ。本発明者等はこ
れにヒントを得、さらにこれを発展させて、イチョウ抽
出物を緑茶、紅茶、麦茶、ウーロン茶等のタンニン含有
飲料に添加せしめ、苦味の和らいだイチョウ抽出物入り
健康飲料を開発することに成功し、本発明を完成した。As a result of repeated studies aimed at developing a beverage that would mask the bitterness of ginkgo biloba extract, the present inventors discovered that bitterness could be masked by coexisting tannins in an aqueous solution of ginkgo biloba extract. did. In other words, this is because the astringency of the tannin itself takes precedence over the bitterness derived from the ginkgo extract, and in fact, the ginkgo extract contains 0.1% to 0.
When an aqueous solution containing 4% tannin and an aqueous solution containing 0.1% tannin were compared in a sensory test conducted by 10 panelists, all 10 found the former to be bitter, and the latter to be astringent. Just taste it, you'll know. The present inventors took a hint from this and further developed it by adding ginkgo biloba extract to tannin-containing beverages such as green tea, black tea, barley tea, and oolong tea to develop a health drink containing ginkgo biloba extract with a mild bitterness. They were very successful and completed the present invention.
発明の構成 本発明は茶にイチョウ抽出物を含有する健康茶である。Composition of the invention The present invention is a health tea containing ginkgo biloba extract.
本発明のイチョウ抽出物はギンコイツクアシド、ビロボ
ール等の低極性フェノールを含有せず、ギンコライド、
ビロバライド等のテルペン類、あるいは、ケルセチン配
糖体、ケンフェロール配糖体等のフラボン配糖体のいず
れかまたは両者を含むものであり、例えば、乾燥イチョ
ウ葉を含水低級アルコールで抽出した後得られた抽出物
より脂溶性有機溶媒を用いて低極性化合物を除くか、あ
るいはさらに、水と混和しない有機溶媒により抽出する
といった公知の方法により製造することが出来る。抽出
物中のフラボン配糖体やテルペン類の定性確認、並びに
定敞は薄層クロマトグラフィーや高速液体クロマトグラ
フィーによって容易に行ナウコとができろ。The ginkgo biloba extract of the present invention does not contain low polar phenols such as ginkgosquaside and birobol, and does not contain ginkgolides,
It contains terpenes such as bilobalide, or flavone glycosides such as quercetin glycoside and kaempferol glycoside, or both.For example, it is obtained after extracting dried ginkgo biloba leaves with a hydrous lower alcohol. It can be produced by a known method such as removing low polar compounds from the extracted extract using a fat-soluble organic solvent, or further extracting with an organic solvent that is immiscible with water. Qualitative confirmation and determination of flavone glycosides and terpenes in the extract can be easily performed using thin layer chromatography or high performance liquid chromatography.
本発明に用いられるイチョウ抽出物は、例えば、次のよ
うにして作ることが出来ろ。まず、イチョウ葉を含水エ
タノール中で加熱還流し、葉をデ別して得られるエタノ
ール溶液を濃縮し、その濃縮物に蒸留水とクロロホルム
を加えてクロロホルム可溶部を除き、水層乞メチルエチ
ルケトンで抽出する。抽出物にエタノールを加え不溶物
を除いた後、エタノールを濃縮乾固してイチョウ葉抽出
物とする。The ginkgo biloba extract used in the present invention can be produced, for example, as follows. First, ginkgo leaves are heated to reflux in water-containing ethanol, the leaves are separated, the resulting ethanol solution is concentrated, distilled water and chloroform are added to the concentrate, the chloroform-soluble part is removed, and the aqueous layer is extracted with methyl ethyl ketone. . After adding ethanol to the extract to remove insoluble materials, the ethanol is concentrated to dryness to obtain a ginkgo biloba leaf extract.
本発明に用いられる茶としては緑茶、紅茶。The teas used in the present invention include green tea and black tea.
麦茶、ウーロン茶等の茶類の浸出液あるいは、同茶類の
粉末などである。These include infusions of teas such as barley tea and oolong tea, or powders of the same teas.
本発明の実施の態様としては茶類の浸出液にイチョウ抽
出物を配合した液状の健康茶、あるいは茶類の粉末と混
合しティーバック形態で提供jることも出来る。As an embodiment of the present invention, it is also possible to provide a liquid health tea in which ginkgo biloba extract is blended with tea infusion, or in the form of a tea bag by mixing it with tea powder.
不発明に於てはイチョウ抽出物の添加割合は任意の割合
で用いろことが出来るが苦味をおさえ、且つ、医療効果
を発揮させろ1こめには、上記の方法で抽出した抽出物
を用いる場合、茶類の粉末に対し0.1〜5%(W/V
)に調製することが望ましい。なお、イチョウ抽出物中
のフラボン配糖体やテルペン類は溶解性が良いので最終
製品中で分離することはない。In the case of non-invention, the addition ratio of ginkgo biloba extract can be used at any ratio, but in order to suppress the bitter taste and to exert the medical effect, the extract extracted by the above method is used. , 0.1-5% (W/V
) is desirable. Note that the flavone glycosides and terpenes in the ginkgo biloba extract have good solubility, so they do not separate in the final product.
発明の効果
このようにして製造されたイチョウ抽出物入り健康茶に
は、フラボン配糖体やテルペン類の苦味成分が含まれて
おり、脳卒中や老人ボケの予防や治療効果が期待できる
。しかもイチョウ抽出物の苦味が、茶類の浸出液中に含
まれるタンニン類によりマスクされるため、イチョウ坤
出物に由来する苦味を良しとしない飲用者にも満足され
得るものとなった。Effects of the Invention The health tea containing ginkgo biloba extract produced in this manner contains bitter components such as flavone glycosides and terpenes, and is expected to have preventive and therapeutic effects on stroke and senility. Moreover, since the bitterness of the ginkgo biloba extract is masked by the tannins contained in the tea infusion, even drinkers who do not like the bitterness derived from ginkgo biloba extracts can be satisfied.
実施例 次に実施例と、その製品の風味試験の結果を示す。Example Next, examples and the results of flavor tests of the products will be shown.
実施例1〜3
緑茶、紅茶、麦茶、ウーロン茶の粉末、各2gと第1表
に示した量のイチョウ抽出物を混合してティーバッグと
し、90℃以上の熱湯150m7の入ったカップ中でこ
れを浸出させ浸出液を得た。Examples 1 to 3 2 g each of green tea, black tea, barley tea, and oolong tea powders were mixed with ginkgo biloba extract in the amount shown in Table 1 to make a tea bag, and the bag was placed in a cup containing 150 m7 of boiling water at 90°C or higher. was leached to obtain a leachate.
比較例1〜4として、実施例1〜4と同量のイチョウ抽
出物を含有する水溶液、及び比較例5〜8として異性化
糖5%とシヨ糖0.5%を加えた水溶液に実施例1〜4
と同量のイチョウ抽出物添加した溶液を作り風味試験を
行った。Comparative Examples 1 to 4 are an aqueous solution containing the same amount of ginkgo extract as Examples 1 to 4, and Comparative Examples 5 to 8 are an aqueous solution containing 5% high fructose sugar and 0.5% sucrose. 1-4
A flavor test was conducted by making a solution containing the same amount of ginkgo biloba extract.
風味試験は実施例1〜4及び、比較例1〜8につき10
名のパネラ−による官能テストで行ない、それぞれイチ
ョウ抽出物を含まないコントロールに比べ強い苦味を覚
えるか否かを判定した。結果を第2表に示す。マトリッ
クス中の数字はコントロールに比べ強い苦味を感じたパ
ネラ−の人数を示す。Flavor test was 10 for Examples 1 to 4 and Comparative Examples 1 to 8.
A sensory test was conducted by a panel of experts to determine whether each product had a stronger bitter taste compared to a control that did not contain ginkgo extract. The results are shown in Table 2. The numbers in the matrix indicate the number of panelists who felt the bitterness was stronger than the control.
この試験結果から、イチョウ抽出物は茶類の浸出液中に
溶解させることにエリその苦味を和らげることが出来、
したがってこれより成るイチョウ抽出物入り健康茶は苦
味を良しとしない飲用者にも充分提供しうるものである
ことが判った。From this test result, ginkgo biloba extract can be dissolved in tea infusion to alleviate the bitter taste of tea.
Therefore, it has been found that the ginkgo biloba extract-containing health tea made from this tea can be satisfactorily provided even to drinkers who do not like the bitter taste.
第1表 第2表Table 1 Table 2
Claims (2)
るイチョウ抽出物入り健康茶。(1) Healthy tea containing ginkgo biloba extract, which is characterized by containing ginkgo biloba extract in tea.
ル等の低極性フェノールを含有せず、ギンコライド、ビ
ロバライド等のテルペン類、あるいはケルセチン配糖体
、ケンフェロール配糖体等のフラボン配糖体のいずれか
、または両者を主成分として含有することを特徴とする
特許請求の範囲第1項記載のイチョウ抽出物入り健康茶
。(2) Ginkgo biloba extract does not contain low polar phenols such as ginkgoic acid and bilobol, and contains either terpenes such as ginkgolide or bilobalide, or flavone glycosides such as quercetin glycoside or kaempferol glycoside. The ginkgo extract-containing health tea according to claim 1, characterized in that the ginkgo extract-containing health tea contains , or both as main ingredients.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10527986A JPS62262947A (en) | 1986-05-08 | 1986-05-08 | Health tea containing ginkgo extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10527986A JPS62262947A (en) | 1986-05-08 | 1986-05-08 | Health tea containing ginkgo extract |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62262947A true JPS62262947A (en) | 1987-11-16 |
JPH0575368B2 JPH0575368B2 (en) | 1993-10-20 |
Family
ID=14403231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10527986A Granted JPS62262947A (en) | 1986-05-08 | 1986-05-08 | Health tea containing ginkgo extract |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62262947A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0249544A (en) * | 1988-08-11 | 1990-02-19 | Nonogawa Shoji:Kk | Ginkgo ingredient-containing food and drink |
CN1054028C (en) * | 1993-07-23 | 2000-07-05 | 邱芳龙 | Health tea added with gingko nut and pueraria root extract |
KR100385311B1 (en) * | 2000-10-11 | 2003-05-23 | 박화목 | Process for preparing ginkgo-tea and ginkgo-tea prepared thereby |
CN102578322A (en) * | 2012-02-21 | 2012-07-18 | 徐州绿之野生物食品有限公司 | Ginkgo oolong tea and preparation method thereof |
CN102613348A (en) * | 2012-04-17 | 2012-08-01 | 徐州绿之野生物食品有限公司 | Ginkgo biloba oolong tea and preparation method of ginkgo biloba oolong tea |
JP2020092694A (en) * | 2018-11-30 | 2020-06-18 | 花王株式会社 | Oral composition |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5237079A (en) * | 1975-09-18 | 1977-03-22 | Matsushita Electric Ind Co Ltd | Impedance measuring device |
-
1986
- 1986-05-08 JP JP10527986A patent/JPS62262947A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5237079A (en) * | 1975-09-18 | 1977-03-22 | Matsushita Electric Ind Co Ltd | Impedance measuring device |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0249544A (en) * | 1988-08-11 | 1990-02-19 | Nonogawa Shoji:Kk | Ginkgo ingredient-containing food and drink |
CN1054028C (en) * | 1993-07-23 | 2000-07-05 | 邱芳龙 | Health tea added with gingko nut and pueraria root extract |
KR100385311B1 (en) * | 2000-10-11 | 2003-05-23 | 박화목 | Process for preparing ginkgo-tea and ginkgo-tea prepared thereby |
CN102578322A (en) * | 2012-02-21 | 2012-07-18 | 徐州绿之野生物食品有限公司 | Ginkgo oolong tea and preparation method thereof |
CN102613348A (en) * | 2012-04-17 | 2012-08-01 | 徐州绿之野生物食品有限公司 | Ginkgo biloba oolong tea and preparation method of ginkgo biloba oolong tea |
JP2020092694A (en) * | 2018-11-30 | 2020-06-18 | 花王株式会社 | Oral composition |
Also Published As
Publication number | Publication date |
---|---|
JPH0575368B2 (en) | 1993-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5910308A (en) | Herbal extract composition containing gynostemma pentaphyllum, crataegus pinnatifida and camellia sinensis | |
JP4742752B2 (en) | Beverage production method | |
JP3131448B2 (en) | Ginseng method and processed ginseng produced by it | |
Suna et al. | Trends and possibilities of the usage of medicinal herbal extracts in beverage production | |
JPS62262947A (en) | Health tea containing ginkgo extract | |
CN104256024A (en) | Blood-fat-reducing coffee | |
JPS6221768B2 (en) | ||
US2115411A (en) | Preparation of yerba mate | |
JPS62205028A (en) | Health drink containing ginkgo extract | |
JP4620783B2 (en) | Functional food composition having therapeutic effect on allergy, natural tea using the same, and method for producing the same | |
KR100994250B1 (en) | Onion drink composition | |
JPH04158771A (en) | Method for improving taste of tea and herb, etc., with coffee and drinking composition | |
JPH06183985A (en) | Preventive and therapeutic agent for bone resorption disease | |
EP0720818A1 (en) | Corrigent for coffee | |
JPH0550254B2 (en) | ||
CN114831195A (en) | Preparation method of anoectochilus roxburghii health-preserving tea | |
CN106720755A (en) | A kind of corn stigma bitter leaves tea beverage and preparation method thereof | |
KR0139381B1 (en) | Health drinks including green tea | |
JP2000139392A (en) | Method for processing ginkgo leaf and product of ginkgo leaf processed by the method | |
KR20040094961A (en) | Composition of herb tea powder, coffee powder, greentea powder for anti-obeseness and liquid thereof | |
JPS6160075B2 (en) | ||
CN108142618A (en) | Jasmine tea electuary and preparation method thereof | |
JPH0231646A (en) | Ginkgo extract-containing chocolate | |
KR20170033467A (en) | A process for the preparation of saengmaekssan beverage having improved sensuality and the saengmaekssan beverage prepared therefrom | |
JPH0662797A (en) | Purification of panax ginseng extract and panax ginseng-containing beverage |